Pulmonary Medicine - Global Neurology Academy

1-4 of 4

Improving Survival and Function in Pediatric TK2d with Nucleoside Therapy
Improving Survival and Function in Pediatric TK2d with Nucleoside Therapy
Clinician's Roundtable
Improving Survival and Function in Pediatric TK2d with Nucleoside Therapy
- Charles Turck, PharmD, BCPS, BCCCP
- Caterina Garone, MD, PhD
Uncovering the Disease Burden of Untreated Pediatric TK2 Deficiency
Uncovering the Disease Burden of Untreated Pediatric TK2 Deficiency
Clinician's Roundtable
Uncovering the Disease Burden of Untreated Pediatric TK2 Deficiency
- Charles Turck, PharmD, BCPS, BCCCP
- Cristina Domínguez González, MD, PhD
Understanding the Caregiver Burden in TK2 Deficiency: New Insights from a Study
Understanding the Caregiver Burden in TK2 Deficiency: New Insights from a Study
Clinician's Roundtable
Understanding the Caregiver Burden in TK2 Deficiency: New Insights from a Study
- Charles Turck, PharmD, BCPS, BCCCP
- Philip Yeske, PhD
Expanding on the Neurologic Effects of COVID-19
Expanding on the Neurologic Effects of COVID-19
NeuroFrontiers
Expanding on the Neurologic Effects of COVID-19
- Andrew Wilner, MD, FACP, FAAN
- Jennifer Frontera, MD